End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.05 CNY | +1.26% | +1.26% | -19.66% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-19.66% | 601M | - | ||
+15.84% | 35.85B | B+ | ||
+0.47% | 4.47B | B+ | ||
+40.21% | 1.47B | - | - | |
-0.96% | 1.36B | - | - | |
-24.75% | 779M | - | ||
-22.13% | 767M | - | - | |
-15.51% | 754M | - | ||
-39.47% | 631M | - | ||
-13.70% | 440M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 300041 Stock
- Ratings Hubei Huitian New Materials Co., Ltd.